Gender differences in depression, anxiety, and quality of life in Parkinson’s disease before and after deep brain stimulation surgery: a multicentre cohort study

TY - JOUR

T1 - Gender differences in depression, anxiety, and quality of life in Parkinson’s disease before and after deep brain stimulation surgery

T2 - a multicentre cohort study

AU - Abbott, Molly G.

AU - Ahmed, Arteen

AU - Pavese, Nicola

AU - Macerollo, Antonella

AU - Newman, Edward J.

AU - Farah, Jibril Osman

AU - Sarangmat, Nagaraja

AU - Misbahuddin, Anjum

AU - Ledingham, David

AU - GIbbs, Michelle

AU - Mills, Russell

AU - Ashkan, Keyoumars

AU - Silverdale, Monty

AU - Samuel, Michael

AU - Okai, David

AU - Shotbolt, Paul

N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.

PY - 2025/9/30

Y1 - 2025/9/30

N2 - Background Disproportionately fewer females with Parkinson’s disease (PD) undergo deep brain stimulation surgery (DBS). Some data show worse depression, anxiety, and quality of life (QOL) in females with PD. Investigations into these gender disparities, or the effect of DBS on these non-motor symptoms, remain limited. Methods 61 PD patients across seven UK DBS centres were recruited for the Clinical Response of Impulsive behaviours to deep brain Stimulation in PD (CRISP) prospective cohort study. Questionnaires measured primary outcomes of depression (Patient Health Questionnaire-9), anxiety (Generalised Anxiety Disorder-7) and QOL (Parkinson’s Disease Questionnaire-39) before and 6months after bilateral subthalamic nucleus DBS, and secondary outcomes of predictors of postoperative changes in mood. Results Females were disproportionately under-referred for DBS (28% of cohort). Baseline depression and anxiety were similar between genders. While DBS significantly improved overall anxiety (p<0.001), females reported significantly more postoperative anxiety than males (median score 7 vs 1.5, Cohen’s d=0.33, p=0.009). Postoperatively, only males experienced a significant reduction in moderate depression, by 29% (p=0.004) (12% in females). QOL improved significantly by similar proportions, thus significantly worse QOL in females preoperatively was sustained as 9.12% worse postoperatively (Cohen’s d=0.75, p=0.02). Preoperatively, females reported significantly worse mobility, social support, and pain; postoperatively, the significant difference in mobility was sustained. Longer PD duration, worse QOL, and mobility predicted postoperative depression (R2 =0.156, p=0.003), while female gender and reduced social support predicted postoperative anxiety (R2=0.23, p<0.001). Conclusions DBS showed clinical efficacy for non-motor PD symptoms across genders, evidencing the need to close the gender gap in DBS. Analysis by gender highlighted significant disparities and postoperative predictors that provide impetus for tailored DBS counselling.

AB - Background Disproportionately fewer females with Parkinson’s disease (PD) undergo deep brain stimulation surgery (DBS). Some data show worse depression, anxiety, and quality of life (QOL) in females with PD. Investigations into these gender disparities, or the effect of DBS on these non-motor symptoms, remain limited. Methods 61 PD patients across seven UK DBS centres were recruited for the Clinical Response of Impulsive behaviours to deep brain Stimulation in PD (CRISP) prospective cohort study. Questionnaires measured primary outcomes of depression (Patient Health Questionnaire-9), anxiety (Generalised Anxiety Disorder-7) and QOL (Parkinson’s Disease Questionnaire-39) before and 6months after bilateral subthalamic nucleus DBS, and secondary outcomes of predictors of postoperative changes in mood. Results Females were disproportionately under-referred for DBS (28% of cohort). Baseline depression and anxiety were similar between genders. While DBS significantly improved overall anxiety (p<0.001), females reported significantly more postoperative anxiety than males (median score 7 vs 1.5, Cohen’s d=0.33, p=0.009). Postoperatively, only males experienced a significant reduction in moderate depression, by 29% (p=0.004) (12% in females). QOL improved significantly by similar proportions, thus significantly worse QOL in females preoperatively was sustained as 9.12% worse postoperatively (Cohen’s d=0.75, p=0.02). Preoperatively, females reported significantly worse mobility, social support, and pain; postoperatively, the significant difference in mobility was sustained. Longer PD duration, worse QOL, and mobility predicted postoperative depression (R2 =0.156, p=0.003), while female gender and reduced social support predicted postoperative anxiety (R2=0.23, p<0.001). Conclusions DBS showed clinical efficacy for non-motor PD symptoms across genders, evidencing the need to close the gender gap in DBS. Analysis by gender highlighted significant disparities and postoperative predictors that provide impetus for tailored DBS counselling.

KW - DEPRESSION

KW - NEUROSURGERY

KW - PARKINSON'S DISEASE

UR - https://www.scopus.com/pages/publications/105018056983

U2 - 10.1136/bmjno-2025-001246

DO - 10.1136/bmjno-2025-001246

M3 - Article

AN - SCOPUS:105018056983

SN - 2632-6140

VL - 7

JO - BMJ Neurology Open

JF - BMJ Neurology Open

IS - 2

M1 - e001246

ER -